Search
Home
Catalog
2
Help
Help
Contact Us
FAQ
Jump to content
AMCP Learn
Search
Open menu
Cart
AMCP Learn login
Register
Bookmark/Search this post
Facebook
Twitter
LinkedIn
Forward
Home
Catalog
Help
Contact Us
FAQ
You are here
Home
Search
APFM Section 4 Module 4: Best Practices for Utilizing Formulary Resources
Market Insights Best Practice on Food Allergies Part 1
Redefining Treatment for Hypoparathyroidism in Adults: When Patients Are Inadequately Controlled on Conventional Therapy
Identifying the Managed Care Impact of Bipolar Disorder: Treatment Advancements, Accurate Diagnosis, and Equitable Care
Thirty Years of Targeted Immuno-Modulators Evolution: More of the Same or Formulary Necessity?
A Preventive Treatment Option for Adults with Migraine
A CGRP Receptor Antagonist for the Acute Treatment of Migraine: Focus on Early Treatment
APFM Section 2 Module 1: P&T Committee
APFM Section 1 Module 2: Utilization Management
AMCP Market Insights: Idiopathic Hypersomnia
APFM Section 4 Module 3: Strategies for Monitoring the Formulary
CY 2025 Part D Redesign: A Medicare Odyssey
AI and Aging: Implementing New Technology to Optimize Outcomes
Non-alcoholic Steatohepatitis (NASH) Emerging Market: Preparing Managed Care for Early Intervention, Equitable Access, and Integrating the Patient Voice
Evaluating Biosimilar Real-World Evidence, Ongoing Trends, and Market Expansion in Rheumatology
Rezurock® (belumosudil) Clinical Efficacy and Safety on cGVHD Patients
AMCP Market Insights: Managed Care Approaches to Address Unmet Patient Needs in Multiple Sclerosis (MS)
Advancing Schizophrenia Management Strategies in the Patient Journey: Treatment Innovations, Adherence, and Health Outcomes
Rare Disease Spotlight: Transthyretin Amyloidosis Cardiomyopathy (ATTR‐CM) Disease Burden, Unmet Needs, and Treatment Advances
Regulatory Briefing: Marketplace Integrity and Affordability Proposed Rule
Optimizing Healthcare Outcomes: Clinical Advancements, Economic Impact of RYONCIL in Treating Pediatric SR-aGVHD
(L1) Legislative Impacts on Site of Service: What is the Big Deal?
(R1) Unlocking the Value of Real-World Evidence (RWE): Insights for Payers and Manufacturers
(W1) The Regulatory Landscape of AI in Managed Care Pharmacy: Compliance, Ethics, and Future Trends
(L3) Federal Legislative and Regulatory Update
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »